Tumstatin, the NC1 domain of α3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth

This publication has 88 references indexed in Scilit:

• RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis
  Cancer Cell, 2003
• Clinical translation of angiogenesis inhibitors
  Nature Reviews Cancer, 2002
• Integrins
  Cell, 2002
• New functions for the matrix metalloproteinases in cancer progression
  Nature Reviews Cancer, 2002
• Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins
  Nature Medicine, 2002
• The α3(IV)185–206 Peptide from Noncollagenous Domain 1 of Type IV Collagen Interacts with a Novel Binding Site on the β3Subunit of Integrin αvβ3 and Stimulates Focal Adhesion Kinase and Phosphatidylinositol 3-Kinase Phosphorylation
  Journal of Biological Chemistry, 2000
• Regulation of Tumor Cell Chemotaxis by Type IV Collagen Is Mediated by a Ca2+-dependent Mechanism Requiring CD47 and the Integrin αVβ3
  Published by Elsevier ,2000
• The Hallmarks of Cancer
  Cell, 2000
• Inhibition of Tumor Cell Proliferation by Type IV Collagen Requires Increased levels of cAMP
  Connective Tissue Research, 1999
• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Published by Elsevier ,1996